Lcatibant: 5-10mg*10 vials

Product Description: Lcatibant

Introduction
Lcatibant is a synthetic peptide used in scientific research for its potential effects on the bradykinin receptor system. As an investigational compound, it has been explored for its ability to modulate certain biological processes, particularly those associated with the bradykinin B2 receptor. Lcatibant is of interest to researchers studying inflammatory responses, vascular permeability, and other processes regulated by bradykinin. It is important to note that Lcatibant is intended solely for research purposes and not for any therapeutic or clinical applications.

What is Lcatibant?
Lcatibant is a synthetic peptide that acts as a bradykinin B2 receptor antagonist. Bradykinin is a peptide involved in the regulation of blood pressure, vascular permeability, and inflammatory processes. Lcatibant works by blocking the binding of bradykinin to its receptor, which is found on various cells and tissues. By inhibiting the activity of bradykinin, Lcatibant is useful in research investigating the role of this peptide in regulating physiological responses, particularly in the context of inflammation and vascular function.

Potential Different Names

• Lcatibant (generic name)
• Firazyr (brand name)
• Bradykinin B2 Receptor Antagonist

Chemical Formula

• C56H82N18O10S2

Structure
Lcatibant is a cyclic peptide composed of a specific sequence of amino acids that allows it to bind selectively to the bradykinin B2 receptor. It is characterized by a relatively complex structure with multiple peptide bonds and specific amino acid residues that interact with the receptor. The sequence and structure of Lcatibant facilitate its ability to block bradykinin activity, making it a valuable tool in research on bradykinin-related pathways.

How Does It Work?
Lcatibant functions as a bradykinin B2 receptor antagonist. Bradykinin, a naturally occurring peptide, typically binds to the B2 receptor, triggering various biological effects such as vasodilation and increased vascular permeability. These effects are involved in processes like inflammation and the regulation of blood flow. By blocking the bradykinin B2 receptor, Lcatibant inhibits the actions of bradykinin, allowing researchers to study the effects of bradykinin signaling inhibition on various cellular and tissue responses. The ability of Lcatibant to interfere with bradykinin signaling makes it a valuable research tool for understanding the physiological processes that involve this receptor.

Lcatibant's mechanism of action involves binding to the bradykinin B2 receptor and preventing bradykinin from exerting its normal effects. This provides insight into how modulating bradykinin receptor activity might influence various biological systems, including inflammatory and vascular responses.

Conclusion
Lcatibant is a synthetic peptide that serves as a valuable tool for research on bradykinin receptor activity. By selectively blocking the bradykinin B2 receptor, it allows researchers to investigate the role of bradykinin in various biological processes, particularly those related to inflammation, vascular permeability, and blood pressure regulation. Ongoing studies continue to explore the full range of applications for Lcatibant in scientific research, making it an important compound for advancing the understanding of bradykinin-related pathways.

Disclaimer
Lcatibant is for research purposes only and is not intended for human or animal consumption. It is not approved for medical, therapeutic, or diagnostic use. This product description is intended for informational purposes and does not make any health-related claims. Researchers should adhere to all relevant safety guidelines and regulations when handling Lcatibant and ensure compliance with applicable laws concerning its use.